Cargando…

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy

BACKGROUND: Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfeminine individuals who have not had orchidectomy; however, there is no evidence to guide optimal treatment choice. OBJECTIVE: We aimed to compare add-on cyproterone acetat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angus, Lachlan, Leemaqz, Shalem, Ooi, Olivia, Cundill, Pauline, Silberstein, Nicholas, Locke, Peter, Zajac, Jeffrey D, Cheung, Ada S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612061/ https://www.ncbi.nlm.nih.gov/pubmed/31234145 http://dx.doi.org/10.1530/EC-19-0272

Ejemplares similares

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia
por: Cheung, Ada S., et al.
Publicado: (2018)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Pelvic Pain in Transgender People Using Testosterone Therapy
por: Zwickl, Sav, et al.
Publicado: (2023)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study
por: Even-Zohar, Naomi, et al.
Publicado: (2020)

Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals
por: Nolan, Brendan J., et al.
Publicado: (2022)

Voltammetric Determination of Cyproterone Acetate in Pharmaceutical Preparations
por: El-Enany, Nahed, et al.
Publicado: (2010)

Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial
por: Nolan, Brendan J., et al.
Publicado: (2023)

Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Bone Microarchitecture in Transgender Adults: A Cross‐Sectional Study
por: Bretherton, Ingrid, et al.
Publicado: (2022)

Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study
por: Nolan, Brendan J, et al.
Publicado: (2022)

LBODP089 Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Correction to: Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Persistent hypoaldosteronism post-adrenalectomy for primary aldosteronism – a role for pre-operative spironolactone?
por: Angus, Lachlan M, et al.
Publicado: (2021)

Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor
por: Chen, Chih-Shou, et al.
Publicado: (2021)

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma.
por: Keating, J. J., et al.
Publicado: (1989)

Unilateral proptosis and blindness caused by meningioma in a patient treated with cyproterone acetate
por: Sys, Celine, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

SAT397 A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment
por: Korpaisarn, Sira, et al.
Publicado: (2023)

The impact of the first three months of the COVID-19 pandemic on the Australian trans community
por: Zwickl, Sav, et al.
Publicado: (2021)

A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas
por: Lee, Keng Siang, et al.
Publicado: (2022)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.
por: Thompson, P., et al.
Publicado: (1991)

Regression of Giant Olfactory Groove Meningioma and Complete Visual Acuity Recovery after Discontinuation of Cyproterone Acetate
por: Bernat, Anne Laure, et al.
Publicado: (2018)

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
por: Portet, Sylvain, et al.
Publicado: (2019)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Is paternal oxytocin an oxymoron? Oxytocin, vasopressin, testosterone, oestradiol and cortisol in emerging fatherhood
por: Bakermans-Kranenburg, Marian J., et al.
Publicado: (2022)

SUN-242 The Utility of Potassium Monitoring in Transgender Adolescents Taking Spironolactone
por: Millington, Kate, et al.
Publicado: (2019)

The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
por: Hayes, Hailey, et al.
Publicado: (2022)

Double-Blind, Placebo-Controlled Trial of Cyproterone Acetate to Prevent Flare-Up Effect on Dogs Implanted With Deslorelin
por: Masson, Sylvia, et al.
Publicado: (2021)

The effect of testosterone, dihydrotestosterone and oestradiol on the re-initiation of spermatogenesis in the adult photoinhibited Djungarian hamster
por: Meachem, Sarah J, et al.
Publicado: (2007)

Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021)

Flutamide versus a cyproterone acetate-ethinyl estradiol combination in moderate acne: a pilot randomized clinical trial
por: Adalatkhah, Hassan, et al.
Publicado: (2011)

Cyproterone Acetate Mediates IRE1α Signaling Pathway to Alleviate Pyroptosis of Ovarian Granulosa Cells Induced by Hyperandrogen
por: Zhang, Yan, et al.
Publicado: (2022)

Oestradiol-17β plasma concentrations after intramuscular injection of oestradiol benzoate or oestradiol cypionate in llamas (Lama glama)
por: Cavilla, María V, et al.
Publicado: (2010)

Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
por: Davis, Kimberly H., et al.
Publicado: (2017)

The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning
por: Lippi, Gian, et al.
Publicado: (2017)

Women consuming oral contraceptives containing cyproterone acetate and ethinylestradiol show a higher risk of thyroid cancer than nonusers
por: Lai, Pei-Hsuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2llmufa4tl64oo41182jm94j99